RECURRENT LYMPHOMA
Clinical trials for RECURRENT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted drug shows promise for kids with rare RET-Driven cancers
Disease control OngoingThis study tests a drug called selpercatinib in children and young adults (ages 1 to 21) whose cancers have a specific genetic change called a RET alteration. The goal is to see if the drug can shrink tumors or stop them from growing. The trial is for patients with advanced solid…
Matched conditions: RECURRENT LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Childhood cancer immunotherapy trial pulled before starting
Disease control TerminatedThis study was designed to test two immunotherapy drugs, nivolumab and ipilimumab, in children and young adults with cancers that returned or didn't respond to treatment and have many genetic mutations. The goal was to see if the combination could shrink tumors or help patients l…
Matched conditions: RECURRENT LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New hope for kids with returning cancers: drug blocks tumor growth
Disease control OngoingThis study tests an experimental drug called elimusertib in children and young adults whose solid tumors have returned or not responded to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors by blocking enzymes that cancer cells need to …
Matched conditions: RECURRENT LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes of a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced solid tumors, lymphomas, or multiple myeloma that have not responded to standard therapy are enrolled. The goal is to see if targe…
Matched conditions: RECURRENT LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 05:04 UTC
-
Cancer weight loss study also targets caregiver stress
Knowledge-focused OngoingThis study measures how often cancer patients in a supportive care clinic experience cachexia (unintentional weight loss and appetite loss) and examines the emotional toll on both patients and their primary caregivers. Researchers will track weight changes and use questionnaires …
Matched conditions: RECURRENT LYMPHOMA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC